Published 11 days ago • loading... • Updated 11 days ago

Innate Pharma to participate in the Jefferies Global Healthcare Conference

Summary by WBOC 16

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage

+7 Reposted by 7 other sources

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage

11 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources8

Leaning Left1Leaning Right0Center4Last Updated11 days agoBias Distribution

80% Center

80% Center

Untracked bias

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

innate-pharma.com broke the news 12 days ago on Monday, May 18, 2026.

Sources are mostly out of (0)